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Abstract
The consequences of fetal exposure to alcohol are very diverse and the likely molecular
mechanisms involved must be able to explain how so many developmental processes could go
awry. If pregnant rat dams are fed alcohol, their pups develop abnormalities characteristic of fetal
alcohol spectrum disorders (FASD), but if these rat dams were also treated with choline, the
effects from ethanol were attenuated in their pups. Choline is an essential nutrient in humans, and
is an important methyl group donor. Alcohol exposure disturbs the metabolism of choline and
other methyl donors. Availability of choline during gestation directly influences epigenetic marks
on DNA and histones, and alters gene expression needed for normal neural and endothelial
progenitor cell proliferation. Maternal diets low in choline alter development of the mouse
hippocampus, and decrement memory for life. Women eating low-choline diets have an increased
risk of having an infant with a neural tube or or ofacial cleft birth defect. Thus, the varied effects
of choline could affect the expression of FASD, and studies on choline might shed some light on
the underlying molecular mechanisms responsible for FASD.
Keywords
Choline; Epigenetics; Methyl donor; Alcohol; Single nucleotide polymorphism; Nutrition
Introduction
Exposure of germ cells, fetus, and young infant to alcohol can cause abnormalities in
behavior and organ structures that range from barely detectable, to birth defects, to fetal loss
[1]. Fetal alcohol spectrum disorders (FASD) include growth retardation, distinctive facial
anomalies, cardiac defects, and altered brain function; less commonly, FASD are associated
with skeletal, ocular, vestibular, hepatic, skin, and immune defects [2]. Thus, the
consequences of fetal exposure to alcohol are very diverse and the likely molecular
mechanisms involved must be able to explain how so many developmental pathways could
go awry. Though there are likely many varied mechanisms of damage, Haycock [3] recently
hypothesized that epigenetic factors are among the important mechanisms underlying FASD
based on the important role of epigenetic mechanisms in central nervous system
development.
Though our genetic code is spelled out at the time of conception, humans retain some level
of flexibility about which of our genes is active or suppressed. This is accomplished by an
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epigenetic code which is transmitted by DNA methylation, covalent modifications of
histones and chromatin, and by RNA interference [4]. The pattern of DNA methylation is
first established during gastrulation [5] but can be changed during fetal development and
early life. Haycock argues that epigenetic perturbations could cause the varied sequelae
observed after exposure to alcohol [3]. This concept is strengthened by evidence that chronic
exposure to alcohol perturbs one-carbon metabolism, thereby altering the key substrates
needed to methylate DNA and histones [6].
A parallel line of investigation seems to lead to the same conclusion—that FASD may be
caused by epigenetic perturbations at the time that progenitor cells are dividing and
differentiating to form organs. Children with FASD have a perturbation in one-carbon
metabolism that is reflected in a decreased choline/creatine ratio in brain (left striatum) [7].
In 2009, Thomas and colleagues [8] reported that when pregnant rat dams were exposed to
ethanol during gestational days 5–20, their offspring had reduced birth weight and brain
weight, delays in eye opening and incisor emergence, and alterations in the development of
the righting reflex, geotactic reflex, cliff avoidance, reflex suspension, and hindlimb
coordination. However, if rat dams were also treated with choline, the effects from ethanol
were attenuated (on birth and brain weight, incisor emergence, and most behavioral
measures) in their pups. In fact, behavioral performance of ethanol-exposed pups treated
with choline did not differ from that of controls. This effect from choline occurred without
changing alcohol exposure, as blood alcohol levels were not changed by choline [8]. If
children with FASD have some perturbation in choline metabolism, and choline
supplementation attenuates the effects of alcohol exposure, then perhaps examining choline-
related mechanisms will be of use in understanding the molecular etiology of FASD (Fig. 1).
Choline and Fetal Development
Choline is an essential nutrient for humans [9], and it is needed for biological membrane
formation, for methylation, and for acetylcholine biosynthesis [10]. Choline is found in a
variety of foods ([11]; and see http://www.ars.usda.gov/services/docs.htm?docid=6232; last
accessed 11 Nov 2010), but the richest food sources of choline (eggs and liver) are avoided
by many women. In fact, in the USA, most women do not eat diets delivering the
recommended intake of choline [12]. Newborns have higher tissue choline concentrations
than do their mothers at term (e.g., 10–15-fold higher in rats) [13, 14] because the placenta
effectively takes choline from mother and delivers it to the fetus [15–17]. Later on, mother
keeps supplying the baby with choline, as the mammary gland also delivers choline from
mother to baby in breast milk [18, 19]. Finally, pregnant women may have a higher capacity
to form phosphatidylcholine (a source of choline) from precursors in liver because the gene
PEMT, that encodes the enzyme phosphatidylethanolamine-N-methyltransferase that
catalyzes this process, is induced by estrogen [20]. Thus, there are many physiological
mechanisms that permit women to deliver large quantities of choline to the growing fetus
and infant and, for this to have evolved choline must play some important role in
development.
Rodent dams fed diets low in choline during days 11–17 of gestation had pups with
diminished neural progenitor cell proliferation in fetal hippocampus at the same time that
there was increased apoptosis in these cells [21, 22]. In electrophysiologic studies, an
insensitivity to long-term potentiation (LTP) was measured when these pups were adult
animals [23], and in cognitive studies, they had decremented visuospatial and auditory
memory as adults [24–27]. Conversely, rodent dams fed diets supplemented with choline
(about four times the normal chow levels) during days 11–17 of gestation had pups with
increased sensitivity to LTP when they were adult animals [23], and enhanced visuospatial
and auditory memory as adults [24–27]. During gestation, maternal diets low in choline
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were also associated with increased neural tube closure defects and orofacial defects in
rodent and human fetuses [28–31]. Apparently, choline availability is important for normal
fetal development throughout gestation.
Mechanisms for the Actions of Choline
One of the likely mechanisms for these effects of choline on fetal development is
epigenetically mediated. Choline is a major source of methyl groups [10], and, as discussed
earlier, methylation of DNA and histones are important components of the epigenetic code
[4]. Thus, DNA methylation is altered by availability of dietary choline [32]. DNA can be
methylated on cytosines, and when this nucleotide is methylated in a specific location with
the promoter of a gene, methyl-binding proteins are attracted, forming a complex that
prevents access by transcription factors needed to activate expression of the gene [4]. Thus,
usually methylation inhibits gene expression and hypomethylation increases gene
expression. In the rodent experiments on dietary choline and memory that were described
earlier, dams fed diets low in choline during days 11–17 of gestation had pups with
diminished DNA and histone methylation in genes of the hippocampus [33, 34].
Specifically, a gene (cdkn3) that normally inhibits cell cycling, was hypomethylated and
overexpressed in the prime germinal zone of the dentate gyrus of the fetal hippocampus [34,
35]. The product of this gene, kinase-associated phosphatase (Kap) protein levels were
increased and this subsequently activated the retinoblastoma protein (Rb) pathway that
inhibits cyclin-dependent kinase [34, 35].
In mice, maternal diets low in choline during pregnancy also altered histone methylation in
fetal neural progenitor cells in the areas of the hippocampus where neurogenesis was
occurring (supraventricular and ventricular zones; [33]). Transcriptional repressor neuron-
restrictive silencing factor (REST) binding to gene promoter regions mediates the inhibition
of expression of numerous neuronal genes and is a very important regulator of brain
development [36]. REST recruits a group of co-repressors (histone deacetylase, methyl CpG
binding protein 2 [37], and G9a histone methyltransferase [38]) to the repressor element 1
(RE1) in the promoter of various genes, resulting in inhibition of neuronal gene expression.
The binding of REST at the RE1 site is facilitated by a specific histone methylation pattern
[39]. When neural progenitor cells were exposed to a low-choline environment in vitro,
there was diminished REST binding to RE1 [33]. Thus, availability of choline modulated
histone methylation and thereby gene expression in fetal neural progenitor cells.
Choline effects are not limited to neural progenitor cells. We examined whether maternal
dietary choline modulates angiogenesis in fetal brain [40]. In fetuses from mouse dams fed a
low-choline diet during pregnancy, proliferation of endothelial cells in hippocampus was
decreased because endothelial progenitor cells differentiated prematurely and stopped
dividing [40]. These changes were associated with >25% decrease in the number of blood
vessels in fetal hippocampus in the low-choline group (p<0.01 vs. control). In developing
brain, it is important to maintain a balance between angiogenesis and neurogenesis, and this
is accomplished by careful modulation by local cues (growth factors, extracellular matrix)
[41–45] that include vascular endothelial growth factors (VEGF) and their receptors and by
angiopoietin (ANGPT)/endothelial receptor tyrosine kinase signaling (Tie-2) [46–48].
Cytosines in the promoter regions of vascular endothelial factor C (VEGFC) and
angiopoietin 2 (ANGPT2) were hypomethylated in neural progenitor cells exposed to
choline compared to controls, providing an explanation for why these genes were over
expressed [40]. Expression of genes for these angiogenic signals was increased in fetal
hippocampus in the low-choline group (VEGFC, 2.0-fold, p<0.01 vs. control and ANGPT2,
2.1-fold, (p<0.01 vs. control)) [40]. Thus, maternal dietary choline intake and epigenetic
changes also alter angiogenesis in the developing fetal hippocampus.
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Shared Mechanisms for Effects of Choline and Alcohol?
Several types of tissues (nerves and blood vessels; perhaps others) are capable of changing
epigenetic marks when presented with a low-choline environment. Choline availability
during gestation in rodents modifies DNA methylation, DNA methyltransferase expression,
histone H3 methylation, and histone methyltransferase expression in fetal tissues [33, 34, 49,
50]. However, these effects may occur only during critical windows of time during gestation
when progenitor cells are exposed to proliferation-promoting signals and before they
differentiate. Hippocampal neural progenitor cell proliferation occurs from day 11–17 of
mouse gestation, and that period is when choline exerts its effects. Restoration of choline
later in development may not correct the epigenetic marks. Though not yet proven, it is
likely that other types of progenitor cells, developing at different times during gestation, are
also sensitive to choline. This could explain choline effects on neural tube and cleft palate
defects. Exposure to alcohol also changes epigenetic marks. Maternal exposure to ethanol
during pregnancy resulted in genome-wide hypomethylation in fetuses [51], and to
differential modulation of H19 DNA methylation (controls an important growth factor gene)
in the paternal and maternal alleles in the placenta [52]. Paternal alcohol exposure altered
methylation of imprinted genes in the male gamete and decreased cytosine methyltransferase
mRNA levels in paternal sperm [53, 54]. Thus, alcohol (and perhaps choline) might exert
different effects on the epigenetic regulation of gene expression in the gametes, fetus, and
placenta.
Alcohol and Choline Metabolism
Choline, folate, and methionine metabolism are highly inter-related, and these pathways
intersect at the formation of methionine from homocysteine [10]. Homocysteine can be
methylated using methyltetrahydrofolate or the choline metabolite betaine as the methyl
group donor [10]. Manipulations that reduce the availability of methyl groups from folate
increase the demand for choline and vice versa [55–57]. In rats, ethanol feeding inhibits the
use of folate methyl groups to make methionine (methionine synthetase activity inhibited)
and increases the use of betaine to make methionine (activity of the enzyme betaine–
homocysteine methyl transferase is increased) [58]. Acute ingestion of alcohol in humans
lowers brain concentrations of choline as measured by magnetic resonance spectroscopy (the
choline/creatinine rations measured in such imaging likely measures a mixture of choline-
containing compounds in brain) [59]. In the micropig, transcription of genes and activity for
several other enzymes in one-carbon metabolism is altered by exposure to alcohol (i.e.,
methyltetrahydrofolate reductase, methionine adenosyltransferase 1A, glycine N-
methyltransferase, S-adenosylhomocysteine hydrolase) [60]. In alcoholic liver disease,
methionine metabolism is impaired, and S-adenosylmethionine (formed from methionine)
concentrations in liver are decreased [61]. S-adenosylmethionine is the methyl donor needed
for methylation of DNA and histones. Alcohol exposure also diminishes the availability of
methyltetrahydrofolate, thereby increasing the demand for choline. Diets of alcoholics are
especially deficient in folate [62]. Very low dietary folate intake (<180 µg per day) was 2.5-
fold more common among women who drank 30 g alcohol regularly [63]. Heavy alcohol
users malabsorb folate [64] and increase the loss of folate in the urine through a reduction in
renal tubular reabsorption [65]. It is interesting that, in some animal models, dietary betaine
supplementation attenuates several of the metabolic abnormalities associated with alcohol,
correcting the abnormal hepatic S-adenosylmethionine and homocysteine concentrations and
mitigating some of the damage to the liver [66, 67].
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Could Mechanisms Related to Epigenetics and Choline be the Cause of
FASD?
The consequences of fetal exposure to alcohol include growth retardation; distinctive facial
anomalies; cardiac defects; altered brain function; and skeletal, ocular, vestibular, hepatic,
skin, and immune defects [2]. Choline deficiency during gestation in animal models is
associated with growth retardation, altered brain function, skeletal abnormalities, hepatic
and muscle damage, as well as orofacial and neural tube birth defects [10]. Decreased
choline availability to the fetus decreases hippocampal neurogenesis and increases apoptosis
[68]. Exposure of the fetus to alcohol also decreases hippocampal neurogenesis and
decreases cell survival [69, 70], resulting in reduced numbers of hippocampal pyramidal
cells [71]. Though there are differences in the genes and tissues studied in both models, both
choline deficiency and ethanol alter genes of cell cycling by altering DNA methylation of
these genes [35, 72]. Prenatal alcohol exposure perturbs behavioral development leading to
hyperactivity, motor incoordination, alterations in social processing, and to deficits in
cognitive functioning, and prenatal supplementation with choline prevents or mitigates these
effects [73]. Could there be shared molecular mechanisms that explain how so many
developmental pathways could be altered?
Choline and epigenetics can also influence brain function. As discussed earlier, choline
availability to pregnant rodents alters memory function in their juvenile, adult, and aged
offspring [74]. In a mouse model of Down Syndrome, mice born to mothers supplemented
with choline during the perinatal period had significant improvements in cognitive function
and emotion regulation [75]. Epigenetic mechanisms underlie a number of syndromes in
which brain function abnormalities are apparent, including Rett syndrome, an autism
spectrum disorder that is characterized by cognitive impairments [76]. This syndrome results
from mutations in the methyl DNA-binding protein MeCP2 [77]. Also, there are data
suggesting that epigenetic factors are associated with hyperactivity in children [78] and
certain psychiatric disorders [79]. As a whole, the available data suggests that the underlying
mechanism responsible for the effects of choline could also explain how many
developmental pathways could go awry in FASD.
Clues that Might be of Interest for Future Studies in FASD
Humans have widely varying dietary requirements for choline, in part explained by genetic
variation. As discussed earlier, several metabolic pathways influence how much choline is
required from diet, and single nucleotide polymorphisms (SNPs) in specific genes influence
the efficiency of these pathways. Specifically, some polymorphisms in the folate pathways
limit the availability of methyltetrahydrofolate and thereby increase use of choline as a
methyl donor; polymorphisms in the PEMT gene alter endogenous synthesis of choline; and
polymorphisms in other genes of choline metabolism influence dietary requirements by
changing the utilization of choline moiety [80, 81]. At this time we do not know whether
maternal or fetal SNPs (or some combination of both) are most important in setting demand
for choline. The fact that these SNPs are very common suggests that they could be overcome
by high choline in the diet, perhaps because humans can eat choline to overcome the
inefficiencies associated with the SNPs. If FASD shares some common mechanism with the
effects of choline, then it is possible that people with SNP-induced metabolic inefficiencies
who also eat a low-choline diet are at greater risk for FASD.
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Potential shared mechanisms. Diets low in choline, or genetic variations that increase the
dietary demand for choline, can decrease DNA methylation (converting methyl-cytosines to
cytosines in genes) and this increases gene transcription, changes progenitor cell
proliferation and differentiation, resulting in birth defects and abnormal brain development.
It is possible that similar mechanisms explain how alcohol exposure causes fetal alcohol
spectrum disorders (FASD). Alcohol exposure during pregnancy perturbs one-carbon
metabolism, decreasing the use of folate and increasing the use of choline as a methyl donor
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